Skip to content

The Ataxia Community Comes Together in Orlando April 9–11, 2026 for the Annual Ataxia Conference! LEARN MORE

Ataxia

Snapshot: ¿Qué es una Mutación De Novo?

Para que nuestro cuerpo funcione de manera saludable, es necesario llevar a cabo muchos procesos celulares esenciales regulados por moléculas creadas en nuestro interior. Esta molécula base es llamada ADN, la cual actúa como un manual de instrucciones al llevar toda la información genética de nuestro cuerpo. El genoma de Read More…

Unraveling the Role of Mitochondria in SCA6 Progression

Written by Yujia Li Edited by Priscila Pereira Sena The discovery of first links between mitochondrial dysfunction and SCA6 progression offers new insights for potential treatments. What drives the progression of Spinocerebellar ataxia type 6 (SCA6)? While the exact mechanisms remain unclear, a study by Leung et al. suggests that Read More…

Snapshot: What is the cerebellar cognitive affective syndrome (CCAS) scale?

Cerebellar cognitive affective syndrome (CCAS) is a condition where cognitive and emotional abilities are affected due to cerebellar damage. Historically, the cerebellum was identified as the part of the brain involved in movement and balance, however, CCAS discovery has significantly extended its role in cognition and emotional regulation. The cerebellar Read More…

Snapshot: What is RFC1?

RFC1 is a gene that encodes for replication factor C subunit 1, a component of the protein replication factor C (RFC), which plays an important role in DNA synthesis. RFC recruits DNA polymerase, the protein that assembles the building blocks of DNA, to where the DNA needs to be made. Read More…

Beyond Capicua: Discovery of new proteins implicated in SCA1 pathology

Written by Katerina Pliatsika    Edited by Hannah K Shorrock, PhD Additional proteins which interact with ATXN1 contribute to toxicity in a SCA1 mouse model.  In neurodegenerative diseases, a problematic gene and its resulting protein play a crucial role in the selective loss of brain cells. However, a fundamental question remains unanswered: Read More…

Oligonucleotídeos Antissenso para a Ataxina-3 Mutante pode Melhorar a Disfunção dos Neurônios de Purkinje

Escrito por: Asmer Aliyeva Editado por: Dr. Hannah K Shorrock Traduzido por: Priscila Pereira Sena  Tratamento com Oligonucleotídeo Antisenso (ASO, do inglês Antisense Oligonucleotide) melhora a função dos neurônios de Purkinje regulada por canais de potássio, e destaca a conectividade cerebral alterada na interrupção do movimento na SCA3. Entender quais tipos celulares Read More…

Snapshot: What is the Brief Ataxia Rating Scale (BARS)?

How do you accurately measure something as nuanced as coordination? For clinicians assessing ataxia, this question has driven the development of various rating scales. The Brief Ataxia Rating Scale is one of the scales developed. It is a clinical tool that assesses ataxia severity. However, it is simplified to be Read More…

Translate »

Join the Ataxia community today!

Become a free member for exclusive content from NAF.